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Summary
Clostridium difficile is a prominent nosocomial patho-
gen, proliferating and causing enteric disease in indi-
viduals with a compromised gut microflora. We
characterized the post-translational modification of
flagellin in C. difficile 630. The structure of the modi-
fication was solved by nuclear magnetic resonance
and shown to contain an N-acetylglucosamine substi-
tuted with a phosphorylated N-methyl-L-threonine. A
reverse genetics approach investigated the function
of the putative four-gene modification locus. All
mutants were found to have truncated glycan struc-
tures by LC-MS/MS, taking into account bioinformatic
analysis, we propose that the open reading frame
CD0241 encodes a kinase involved in the transfer of
the phosphate to the threonine, the CD0242 protein
catalyses the addition of the phosphothreonine to the
N-acetylglucosamine moiety and CD0243 transfers
the methyl group to the threonine. Some mutations
affected motility and caused cells to aggregate to
each other and abiotic surfaces. Altering the structure
of the flagellin modification impacted on colonization
and disease recurrence in a murine model of infec-
tion, showing that alterations in the surface architec-
ture of C. difficile vegetative cells can play a
significant role in disease. We show that motility is
not a requirement for colonization, but that coloniza-
tion was compromised when the glycan structure was
incomplete.
Introduction
The intestinal pathogen Clostridium difficile is a strictly
anaerobic, Gram-positive bacterium. In recent years it has
become a huge burden both economically and to human
health due to its global spread throughout health care
environments, where it causes disease ranging from mild
diarrhoea to life threatening pseudomembranous colitis
(Loo et al., 2005; Goorhuis et al., 2007; Kuijper et al.,
2007). Its ability to differentiate into endospores, a meta-
bolically dormant and highly robust cell form, is essential in
its transmission as this allows it to survive external stresses
such as desiccation, osmotic shock, and contact with
chemicals such as disinfectants (Lawley et al., 2010;
Deakin et al., 2012). Two large clostridial toxins, TcdA and
TcdB are considered the main virulence factors associated
with disease symptoms, their production leading to the
disruption and eventual destruction of the intestinal epithe-
lium (Voth and Ballard, 2005). The generation of at least
one of these two potent toxins is essential for the patho-
genesis of this organism (Lyras et al., 2009; Kuehne et al.,
2010); however, other properties of C. difficile contribute to
its success as a pathogen by promoting the colonization of
the host, which may be influential in disease recurrence.
Bacterial surface-associated proteins are often involved
in host colonization and immune evasion (Pizarro-Cerda
and Cossart, 2006). C. difficile produces many such pro-
teins, including peritrichous flagella, a paracrystalline
S-layer, cell wall proteins and a putative sortase and sorted
proteins (Hennequin et al., 2003; Eidhin et al., 2006; Kirby
et al., 2009; Reynolds et al., 2011). Flagella are the orga-
nelles of bacterial propulsion and have been found to be
important for the penetration of the mucous layer and
adherence to the gut mucosa in enteric pathogens (Liu
et al., 1988; Grant et al., 1993), although in C. difficile the
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flagella are not essential for virulence and colonization of
the hamster or murine model (Dingle et al., 2011; Aubry
et al., 2012; Baban et al., 2013).
Flagellin is the main protein component of the flagella; it
forms the long whip-like filament which when rotated by the
basal subunits of the structure causes motility. Some bac-
teria produce ‘simple’ flagella filaments which are com-
posed of a single flagellin, while others produce ‘complex’
flagella filaments made up of multiple flagellins (Logan,
2006). In a number of Gram-positive and Gram-negative
bacteria the flagellin is post-translationally modified with an
O-linked oligosaccharide at serine and/or threonine resi-
dues on the highly variable, surface-exposed domains of
the protein (Logan, 2006). Enzymes, often encoded along-
side the flagella genes, transfer these post-translational
modifications (PTMs) specifically to the flagellin. The
nature of this specificity is yet to be determined as no
consensus sequence is recognized by these enzymes. In
many bacteria these flagellin PTMs are essential for motil-
ity and mutants of the PTM enzymes are not only unable to
modify their flagellin but are also unable to secrete the
flagellin from the cell, as has been described in Campylo-
bacter jejuni, Helicobacter pylori, Caulobacter crescentus,
Aeromonas caviae and Shewanella oneideinsis (Ewing
et al., 2009; Asakura et al., 2010; Faulds-Pain et al., 2011;
Parker et al., 2012; Sun et al., 2013). However, this is not
the case for all bacteria, for example in Pseudomonas
aeruginosa motility is unaffected when flagellin modifica-
tion genes are mutated (Schirm et al., 2004; Verma et al.,
2006).
C. difficile produces a simple flagella filament with a
single flagellin which is post-translationally modified. As
with most bacterial O-linked PTM systems, the genes
encoding the modification enzymes are colocalized with
those encoding the target protein. In C. difficile strains
these enzymes are thought to be encoded among the
flagella structural and regulatory genes, between the
flagellin gene, fliC and the putative flagella basal body rod
gene, flgB (Stabler et al., 2009).
It has been found that the C. difficile flagellin can be
modified with at least two oligosaccharide structures,
herein referred to as type A and type B, and that these
structural variations are strain-specific and reflected in
variations at the genome level (Fig. 1; Twine et al., 2009).
The coding sequence (CDS) immediately downstream of
fliC is conserved in the type A and type B strains and
encodes a putative glycosyltransferase (GT) (Fig. 1A),
which is essential for the modification of the flagellin and
motility but not flagellin secretion or filament formation
(Twine et al., 2009). The sugar associated with the flagellin
protein in both type A and type B oligosaccharide modifi-
cations, has been identified by mass spectrometry to be an
N-acetyl hexosamine (HexNAc) (Twine et al., 2009), sug-
gesting that this first sugar is transferred to the flagellin by
this common GT. Beyond this initial sugar neither the
modification genes nor the structure of the PTMs are
conserved in the type A and type B strains (Smith et al.,
1981; Verma et al., 2006). The type A flagellin modification
was previously proposed to be a methylated aspartic acid
attached to the initial HexNAc via a phosphate bond in the
non-epidemic strain 630 (Twine et al., 2009). The type B
structure was identified among BI-I/NAP-I/ ribotype 027
epidemic strains. The oligosaccharide structure of these
modifications is complex and consists of multiple mono-
saccharide residues which includes a HexNAc moiety
through which the glycan is linked to the protein as well as
Fig. 1. Schematic diagram illustrates the alternative flagellin modification gene loci type A and type B.
A. The flagella structural genes fliC and flgB flank the genes predicted to be involved in flagellin modification in the ribotype 012 strain 630
and the ribotype 027 strains. The gene adjacent to fliC in both loci is a predicted glycosyltransferase (GT) and the ORFs in grey are the
remaining putative modification genes, predicted to be involved in flagellin modification.
B. The predicted modification structures of the type A 630/RT017 strains and the type B RT027 strains. The black hexagon represents a
HexNAc, the white circle represents a phosphate group, Me denotes a methyl group, dark gray triangles represent a deoxyhexose and the
white square a heptose, the light gray diamond represents an unidentified structure.
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two deoxyhexose residues and a heptose (Fig. 1B; Twine
et al., 2009; Hitchen et al., 2010).
It has been hypothesized that as the type B PTM was
identified in BI-I/NAP-I/ ribotype 027 outbreak strains,
while the type A PTM was found in a non-epidemic strain,
the type B PTMs could be contributing to the hyperviru-
lence of these organisms (Stabler et al., 2009; Twine
et al., 2009). In this study however we identified the pres-
ence of the type A loci in the toxin A negative epidemic
ribotype 017 (RT017) strains of C. difficile, indicating that
the relative importance of the type A and type B modifica-
tions might not be easily defined. We investigate the
flagellin type A PTMs in both the 630 strain and an epi-
demic RT017 strain M68. A definitive structure for this
modification was determined by NMR spectroscopy and
the role of the putative modification genes were assessed.
We also investigated the role of motility and flagellin modi-
fication in the colonization of C57BL/6 mice, finding that
motility is not a requirement but that colonization was
compromised when the glycan structure was incomplete.
Results
Orthologues of the type A modification gene cluster are
found only in P. aeruginosa PA01 strains
Molecular typing and sequence analysis has revealed that
there are at least five clonal lineages of C. difficile, des-
ignated clades one to five (He et al., 2010; Stabler et al.,
2012), and that all have been involved in outbreaks of C.
difficile-associated disease. Utilizing ACT comparisons;
putative flagellin modification gene loci were compared
among the five clonal lineages of C. difficile strains. Ortho-
logues of the 630 type A modification genes were found in
only one of these lineages which includes the epidemic
RT017 strains.
To determine whether the type A modification genes are
commonly found associated with flagella genes, BLASTP
analysis was carried out with the sequences of strain 630
open reading frames (ORFs) CD0241, CD0242, CD0243
and CD0244. While orthologues of the ORFs CD0241 and
CD0242 were occasionally identified together in other
genomes (such as Helicobacter hepaticus) they were not
associated with any known structural orthologues such as
the flagella. In fact it was only in strain PA01 of P. aerugi-
nosa where orthologues of CD0241, CD0242 and
CD0243 were clustered together and like C. difficile they
were found within the flagella genetic locus. It was noted
previously that the flagellin modification of the PA01
flagellin was similar to that of C. difficile 630 (Twine et al.,
2009), containing a methylated amino acid (in this case a
tryptophan) attached via a phosphate bond to a deox-
yhexose sugar on the surface of the flagellin (Verma et al.,
2006). The genes PA1088, PA1089 and PA1090, located
directly upstream of the flagellin GT and flagellin genes in
P. aeruginosa PA01 strains, are orthologues of CD0243,
CD0241 and CD0242 respectively and are involved in the
modification of the PA01 flagellin. Their amino acid simi-
larity, location and the similar structure of the modification
indicate that these genes may have a similar function in C.
difficile. No orthologue of the CD0244 ORF was found to
be co-located with the other three ORFs in P. aeruginosa
or any other organism and BLASTP searches only iden-
tified hypothetical proteins.
NMR analysis of the type A flagellin solves the structure
of its post-translational modification
The structure of the C. difficile 630 flagellin glycan has
been previously studied by LC-MS/MS and defined as a
HexNAc sugar carrying a phosphate linked to a moiety
which was suggested to be a methylated aspartic acid
(Fig. 1B). This glycan was attached to the flagellin via the
HexNAc at five sites (S141, S174, T183, S188 and S205
[S = serine and T = threonine]) (Twine et al., 2009).
However, it has since been noted that at a mass of 115 Da
the methylated amino acid is too small to be a methyl-
aspartic acid (129 Da). In order to solve the structure of this
modification, nuclear magnetic resonance (NMR) analysis
of the flagellin glycan was carried out. Glycopeptides were
released from the purified glycoprotein by Proteinase K
treatment and isolated using size-exclusion and anion-
exchange chromatography. Enzymatic hydrolysis did not
cleave all amino acids and the product represented a
mixture of glycosylated short peptides. NMR analysis
using 2D spectra (gCOSY, TOCSY, ROESY, 1H-13C HSQC,
1H-13C HMBC, 1H-31P HMQC) indicated that the single
HexNAc monosaccharide is a N-acetyl-β-glucosamine
(GlcNAc) (all vicinal coupling constants 8–10 Hz), linked to
a serine residue on the flagellin protein (Fig. 2). GlcNAc
was phosphorylated at O-3, which caused a downfield shift
Fig. 2. Schematic diagram illustrates the structure of the C.
difficile 630 flagellar glycan shown in O-linkage to a serine residue,
solved by NMR.
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of H/C-3 signals (Table 1). Additional signals were present,
belonging to HOOC-CHX-CHX-CH3 fragment and a methyl
group (Table 1). HMBC correlations between H/C of the
methyl group and H/C-2 of this fragment indicated that
methyl group was linked to the C-2 through a heteroatom.
By the signal position of the C-2 at 70.5 ppm this heter-
oatom was most probably nitrogen. A downfield shift of the
C-2 signal from its expected position of approximately
55 ppm was thus caused by N-methylation. C-3 carried a
hydroxyl group which followed from the position of the C-3
signal at 73 ppm. The H-3 signal of the amino acid was
shifted to 4.5 ppm due to phosphorylation. Overall this
represents phosphorylated N-methylthreonine, in agree-
ment with MS data indicating the mass of the glycosyl
moiety at 398.1 amu (Fig. 2). Absolute L-configuration and
identity of the N-methylthreonine was confirmed by GC of
its acetylated ester with optically pure 2-octanol.
The linkage between N-methylthreonine and GlcNAc
was determined from the 1H-31P HMQC spectrum which
showed correlations between H-3 of GlcNAc and H-3 of
the N-methylthreonine and the same 31P signal at
−0.5 ppm. To summarize, NMR revealed that the 630
glycan is formed of a single GlcNAc linked to a phos-
phorylated N-methyl-L-threonine at the oxygen at C3 of
the sugar (Fig. 2).
The type A modification genes are essential for motility
in strain 630
Flagellin modification is essential to motility in many organ-
isms which modify their flagellins including C. difficile, in
which mutation of the GT believed to transfer the first sugar
to the flagellin protein causes a loss of motility in 630Δerm
(Twine et al., 2009). To determine whether the other puta-
tive type A modification genes are required for C. difficile
motility, mutations in the 630 ORFs CD0241, CD0242,
CD0243 and CD0244 were generated by Clostron mutage-
nesis in 630Δerm (Table 2 for all strains and plasmids).
These mutants were assessed for motility by different
methods as have been previously described (Twine et al.,
2009; Baban et al., 2013), the most reproducible and quan-
tifiable results were achieved on C. difficile minimal media
(CDMM) motility plates. In all assays the ORFs CD0241,
CD0242 and CD0244 were found to be essential for the
motility of C. difficile 630Δerm, with the normal swimming
phenotype of the parental strain being completely abol-
ished in these mutants, this was also observed in muta-
tions of fliC and the initial GT CD0240 as was previously
described (Fig. 3A; Twine et al., 2009). The non-motile
phenotypes were all restored on complementation in trans
(Fig. 3A), although the phenotypes of the fliC, CD0241 and
CD0244 mutants were not restored to wild type levels. The
mutant of CD0243 formed smaller swarms than the paren-
tal strain; however this difference was not statistically
significant (Fig. 3A).
It was previously observed by Twine and co-workers
that despite being non-motile, the GT CD0240 mutant still
produced polymerized flagella filaments, although they
were truncated and fewer in number compared to the
parental strain (Twine et al., 2009). To determine whether
this was also true of the CD0241, CD0242, CD0243 and
CD0244 putative flagellin modification mutants, we
extracted the cell surface-associated proteins by glycine
extraction and probed them with an anti-FliC antibody on
a Western blot. All mutants were found to still produce
flagellin, although its size varied (Fig. 3B). This is likely to
be caused by alterations in the modifications leading to
changes in the size of the protein.
Individual cells were visualized by negative stain trans-
mission electron microscopy (TEM) by which the pres-
ence of flagella filaments associated with the surface of
the cells in 630Δerm and the CD0241, CD0242, CD0243
and CD0244 (Fig. 3C). On further analysis of these elec-
tron micrographs it was observed that the flagella of the
non-motile mutants of CD0241, CD0242 and CD0244
appeared to clump together, which was not the case for
the motile parental strain, 630Δerm, or the motile mutant
CD0243 whose flagella filaments were distributed evenly
around the cell.
Mutations in the type A modification genes cause
alterations of the PTM
Disruption of the putative GT gene, CD0240, was previ-
ously reported to result in an inability to attach glycan to the
sites of modification on the flagellin (Twine et al., 2009). In
Table 1. NMR data (δ, ppm; Varian INOVA 500 MHz, 25°C) for the C. difficile 630 glycopeptide.
H/C 1 H/C 2 H/C 3 H/C 4 H/C 5 H/C 6 Me
GlcNAc 4.65 3.85 4.17 3.63 3.51 3.79; 3.93
100.1 55.6 79.9 70.5 76.6 61.6
N-Me-L-Thr 3.52 4.51 1.41 2.76
172.0 70.5 73.0 19.6 33.9
Exact mass of glycosyl cation 398.109035.
NAc signals C-1 176.1; H/C-2 2.08/23.8 ppm. 31P at −0.5 ppm.
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order to characterize the role of the remaining type A
modification genes, the flagellin modifications of the
CD0241, CD0242, CD0243 and CD0244 mutants were
examined by Mass Spectrometry. Flagellin was isolated
from wild type and mutant strains by shearing or glycine
extraction and proteins were separated by SDS-PAGE. Gel
bands corresponding to flagellin were excised, digested
with trypsin and analysed by nLC-MS/MS. The corre-
sponding MS/MS spectra were sequenced de novo, and
the identified glycopeptides are listed in Table 3. Tandem
mass spectrometry analyses of flagellin tryptic digests from
the CD0241 mutant showed glycopeptides to be modified
with a single HexNAc moiety. No peptides from the
CD0241 mutant harboured the wild-type 398 Da glycan.
Flagellin isolated from the CD0242 mutant also only har-
boured glycopeptides modified with a single HexNAc
moiety. In contrast, flagellin isolated from the CD0243
mutant showed variable glycan modifications. A number of
glycopeptides were modified with a single HexNAc moiety
(Fig. 4A), and a number of peptides modified with a 384 Da
glycan (Fig. 4B). The MS/MS spectrum of this structure
showed typical peptide fragmentation and a glycan
oxonium ion at m/z 385. Glycan-related fragment ions were
also observed at m/z 284, 186 and 168, identical to the
fragmentation pattern of the wild-type sugar (Twine et al.,
2009). In the high m/z region of the MS/MS spectrum,
neutral losses of 98 and 203 were observed, suggesting
the 384 Da sugar is closely related to the wild type 398 Da
sugar. The sugar structures appear to differ by 14 mass
units, which indicates absence of the methyl group in the
sugar of the CD0243 mutant strain. De novo sequencing of
MS/MS spectra of flagellin from the CD0244 mutant
showed a mixture of glycopeptides, modified with either a
single HexNAc moiety, or the 398 Da wild-type sugar.
In trans complementation of CD0241, CD0242 or
CD0244 mutants either partially or fully restored modifi-
cation of flagellin with the 398 Da wild type sugar
(Table 3). For example, flagellin isolated from the comple-
mented CD0241 mutant, showed glycopeptides modified
with either HexNAc or the wild-type sugar. Flagellin iso-
lated from the CD0242 complement harboured peptides
modified with a 203 Da sugar, 384 Da sugar or the 398 Da
wild-type sugar. Complementation of the CD0244 mutant
appeared to fully restore wild type glycosylation.
Table 2. Bacterial strains and plasmids.
Strain/plasmid Genotype or description Reference(s) or source
Strains
E. coli
Top10 F− mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 nupG recA1 araD139
Δ(ara-leu)7697 galE15 galK16 rpsL(Strr) endA1 λ−
Invitrogen
CA434 E. coli HB101 [F− mcrB mrr hsdS20(rB− mB−) recA13 leuB6 ara-14 proA2 lacY1
galK2 xyl-5 mtl-1 rpsL20(Smr) glnV44 λ−] containing plasmid R702
Williams et al. (1990)
C. difficile
630Δerm Derivative of 630 strain, erythromycin sensitive Hussain et al. (2005)
630Δerm-fliC fliC::CT insertion mutant derived from 630Δerm Twine et al. (2009)
630Δerm-0240 0240 mutant derived from 630Δerm by clostron insertion Twine et al. (2009)
M68Δerm M68Δerm: Derived from M68 by deletion of ermB Faulds-Pain and Wren (2013)
M68ΔfliC M68ΔfliC: Derived from M68 by deletion of fliC Faulds-Pain and Wren (2013)
630Δerm-0241::CT 0241 mutant derived from 630Δerm by clostron insertion This study
630Δerm-0242::CT 0242 mutant derived from 630Δerm by clostron insertion This study
630Δerm-0243::CT 0243 mutant derived from 630Δerm by clostron insertion This study
630Δerm-0244::CT 0244 mutant derived from 630Δerm by clostron insertion This study
M68Δerm-0242::CT 0242 mutant derived from M68Δerm by clostron insertion This study
M68Δerm-0243::CT 0243 mutant derived from M68Δerm by clostron insertion This study
630Δerm-0241 ΔfliC Double mutant fliC deletion mutant derived from 630Δerm-0241::CT This study
630Δerm-0242 ΔfliC Double mutant fliC deletion mutant derived from 630Δerm-0242::CT This study
630Δerm-0244 ΔfliC Double mutant fliC deletion mutant derived from 630Δerm-0244::CT This study
Plasmids
pMTL84151 E. coli – C. difficile shuttle plasmid (pCD6;catP; ColE1+tra) Heap et al. (2009)
pfliC_comp pMTL84151, with C. difficile 630 fliC and its native promoter This study
pMTL84153 E. coli – C. difficile shuttle plasmid (pCD6;catP; ColE1+tra; fdx promoter) Heap et al. (2009)
p0241_comp pMTL84153 with CD0241 cloned behind the fdx promoter This study
p0242_comp pMTL84153 with CD0242 cloned behind the fdx promoter This study
p0244_comp pMTL84153 with CD0244 cloned behind the fdx promoter This study
pMTL007C-E2-CD0241 Clostron plasmid retargeted to CD0241 at 231/232s (DNA 2.0) This study
pMTL007C-E2-CD0242 Clostron plasmid retargeted to CD0242 at 156/157s (DNA 2.0) This study
pMTL007C-E2-CD0243 Clostron plasmid retargeted to CD0243 at 309/310a (DNA 2.0) This study
pMTL007C-E2-CD0244 Clostron plasmid retargeted to CD0244 at 556/557a (DNA 2.0) This study
pMTLAFPfliC pMTL82151 with + /− 630fliC 1200 bp Faulds-Pain and Wren (2013)
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Surface layer extracts of 630Δerm and the modification
mutants were analysed by Western blot with an anti-β-O-
GlcNAc antibody and confirmed the NMR structure that
the initial sugar is a GlcNAc (Fig. 4C). Interestingly, there
was no interaction of this antibody with the 630Δerm
flagellin but it did bind to the flagellins of the CD0241,
CD0242, CD0243 and CD0244 mutants, suggesting that
the further modifications block the epitope for antibody
binding to the GlcNAc residue in the parental strain
glycan. As predicted no binding of the antibody to the
flagellin of the CD0240 mutant, which cannot transfer
glycan to the flagellin, was observed.
Alterations in the flagella PTM causes cell aggregation
When grown in liquid culture we observed that the
CD0240, CD0241, CD0242 and CD0244 mutants all
settle out of the suspension and formed sediment at the
bottom of the growth vessel, while cultures of the paren-
tal strain 630Δerm and the CD0243 mutant remained in
suspension (Fig. 5A). This phenotype was restored upon
complementation in trans (Fig. 5A). As all mutants that
formed sediment were also non-motile it was hypoth-
esized that these two phenotypes could be related and
that loss of motility led to sedimentation. However, when
the non-motile aflagellate fliC mutant was grown in liquid
it behaved as the motile parental strain and remained in
suspension, suggesting that loss of motility alone cannot
account for sedimentation of the modification mutants
(Fig. 5A).
In order to quantify this phenotype an assay was devel-
oped which allowed us to determine whether the cells
settled out during growth or at stationary phase and
whether the growth rate was affected by this phenotype.
 
Fig. 3. Motility and flagella production in 630 putative modification mutants.
A. Motility assays of the 630Δerm parental strain compared to the fliC Clostron mutant and the mutations in the predicted modification genes
were carried out in CDMM containing 0.3% Difco-bacto agar. The fliC mutant and the initial GT mutant were non-motile, as described
previously, as were mutations in the ORFs CD0241, CD0242 and CD0244. These were all restored to motility by complementation.
B. Flagellin from 630Δerm and the modification mutants were probed with an anti-FliC antibody by Western blot (MW = molecular weight, gene
names and numbers below indicate mutation, comp = in trans complementation of mutant). All strains with the exception of the fliC mutant
were found to produce flagellin, although the mass of the protein varied.
C. The parental strain 630Δerm and the mutants of CD0241, CD0242, CD0243 and CD0244 were observed by TEM, the black scale bar in
each image represents a length of 1 μm. All of the mutants appeared to have flagella associated with the surface of the cells.
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For this we measured both the optical density (OD) of a well
mixed culture (referred to here as a mixed culture) in order
to assess the overall growth rate of the strains and the
OD600 from the top 1 ml of an undisturbed culture (referred
to here as an unmixed culture), which when compared to
the OD600 of the mixed culture would indicate whether the
cells were coming out of suspension. As the process of
measuring these OD600s involves mixing and altering the
overall volume of the cultures, it meant that two separate
cultures were required for the mixed and unmixed meas-
urements and that new cultures would be required for each
time point tested to avoid distorting the results.
Throughout exponential growth of the parental strain
630Δerm the mixed and unmixed cultures had very
similar OD600s to one another, indicating that during
growth of this strain little sedimentation occurs (Fig. 5B).
At 24 h however the OD600s of the unmixed cultures
were lower than the mixed (OD600 of approximately 0.8
and 1.2 respectively), suggesting that at stationary
phase cells begin to sediment out of solution (Fig. 5B).
No difference was observed in the overall growth of the
fliC mutant compared to 630Δerm. In the unmixed
culture of the fliC mutant the OD600 increases between 3
and 7.5 h, however these OD600s are lower than those of
both the fliC mixed cultures and the 630Δerm unmixed
cultures, indicating that some sedimentation occurs in
this strain during growth (Fig. 5B). By 24 h the OD600 of
the unmixed culture fell to an OD600 of approximately
0.2, while the mixed culture was around 1.0, this differ-
ence in OD600 at this time point is much greater than was
observed in 630Δerm.
In the modification gene mutants CD0241, CD0242 and
CD0244, overall growth was not significantly different to
630Δerm or the fliC mutant, however the sedimentation
phenotype was much more pronounced and no increase
in OD600 was observed in the unmixed culture beyond an
OD600 of approximately 0.2 throughout the exponential
growth phase (Fig. 5C). In line with other phenotypic
observations, the knock-out mutant of CD0243, which
encodes the putative methyltransferase, did not display a
phenotype which was significantly different to the parental
strain (Fig. 5A and C).
While it appears that the loss of the flagellin results in
some sedimentation, mutations in the modification genes
cause a more extreme phenotype which is continuous
throughout growth. We therefore hypothesized that this
phenotype is due to the presence of a flagella filament
lacking the full repertoire of modifications. To address this
hypothesis we took advantage of the recent progress in
genetic tools for C. difficile (Faulds-Pain and Wren, 2013)
and generated in-frame deletions of the fliC gene by allele
exchange in the CD0241, CD0242 and CD0244 clostron
mutant genetic backgrounds. Destructive growth curves
were carried out as before and from the OD600 of the
unmixed cultures it was found that sedimentation did occur
during the growth of all three double mutants (Fig. 5D),
however, unlike the single modification gene mutants,
which remained at an OD600 of approximately 0.2 in the
unmixed cultures, the double mutants did increase during
growth phase, peaking at OD600 of between 0.8 and 1.2 at
7.5 h and had a comparable profile to the fliC single mutant
(Fig. 5B). This supports the hypothesis that the sedimen-
Table 3. Summary of glycan modifications of C. difficile 630 flagellin glycosylation mutants.
Strain/plasmid
Detected glycopeptides
(precursor m/z)
Glycan masses and predicted
composition (Da)
630Δerm Various peptides 398
CD0241 mutant LLDGTSSTIR (633.32+) 203
TMVSSLDAALK (669.82+) 203
CD0241 mutant
p0241_comp
AGGTTGTDAAK (577.32+) 203
TMVSLDAALK (697.42+) 203
TMVSLDAALK (775.32+) 398 (203-80-115)
LLDGTSSTIR (633.32+) 203
LLDGTSSTIR (730.82+) 398(203-80-115)
CD0242 mutant TMVSSLDAALK+ox (677.82+) 203
CD0242 mutant
p0242_comp
TMVSSLDAALK (679.32+) 203
384(203-80-101)
398(203-80-115)
CD0243 mutant LLDGTSSTIR (633.32+) 203
LLDGTSSTIR (732.82+) 384(203-80-101)
TMVSSLDAALK (679.32+) 203
TMVSSLDAALK (724.22+) 384(203-80-101)
CD0244 mutant TMVSSLDAALK (679.32+) 203
TMVSSLDAALK (775.52+) 398(203-80-115)
LLDGTSSTIR (730.82+) 398(203-80-115)
CD0244 mutant
p0244_comp
LLDGTSSTIR (730.82+) 398(203-80-115)
TMVSSLDAALK (775.52+) 398(203-80-115)
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tation which occurs in these modification mutants is chiefly
a consequence of an incompletely modified flagella
filament.
To determine whether these cells are interacting with
one another or with components of the growth medium, the
mutants were tested for autoagglutination. Cells were first
grown on solid BHIS agar then transferred to PBS, all
strains were then normalized by absorbance to a starting
OD600 of 10, as described previously (Howard et al., 2009;
Reynolds et al., 2011). Following incubation overnight,
sedimentation was observed in the CD0240, CD0241,
CD0242 and CD0244 mutants (Fig. 6A). The results were
quantified by calculating the difference between the
absorbance of the top 1 ml of the solution and the absorb-
ance of the whole volume, autoagglutination was calcu-
lated as the percentage of cells that had sedimented
(Fig. 6B). This was found to be between 10 and 20% in the
parental strain, the fliC mutant and the CD0243 mutant but
86% in the CD0240 mutant and between 65% and 72% in
the CD0241, CD0242 and CD0244 mutants.
Alterations in the flagella PTMs leads to increased cell
binding to abiotic surfaces
The autoagglutination observed in the CD0240, CD0241,
CD0242 and CD0244 PTM mutants indicated that these
cells had a ‘stickiness’ that caused them to group together
and as a consequence settle out of solution. To determine
whether this also made them more adherent to abiotic
surfaces, C. difficile strains were grown in 24-well plates for
5 days and the comparative number of cells adhered to the
surface of these plates were quantified by crystal violet
staining (Fig. 6C; Dawson et al., 2012). All of the PTM
mutations lead to an increased interaction with the surface
Fig. 4. Mass spectrometry analyses of C. difficile flagellin tryptic glycopeptides from strain 630Δerm CD0243 mutant. Peptide MS/MS spectra
were obtained from in gel digestion of protein bands from glycine extraction of whole cells.
A. MS/MS spectrum of C. difficile flagellin glycopeptide LLDGTSSTIR. The unmodified peptide ion was observed at m/z 1062, with low
intensity peptide type y and b ions confirming the peptide sequence. A moderately intense HexNAc oxonium ion was observed at m/z 204,
with sequential dehydration giving rise to glycan related ions at m/z 186 and 168. Glycan related fragment ions are indicated with an asterisk.
B. MS/MS spectrum of C. difficile flagellin glycopeptide LLDGTSSTIR, modified with a glycan of 384 Da. The MS/MS spectrum shows the
typical peptide fragment ions and an additional, with a glycan oxonium ion at m/z 385. Glycan related ions were also observed at m/z 284,
186 and 168. In addition, in the higher m/z region of the spectrum neutral losses of 98 and 203 Da were observed. Together these data
suggest the 384 Da glycan moiety is similar to the 398 Da wild type sugar, with the absence of a methyl group. C, Flagellin from 630Δerm and
the modification mutants were analysed by Western blot, probing with an anti-β-O-GlcNAc antibody (MW = molecular weight, gene numbers
below indicate mutation, comp = in trans complementation of mutant). With the exception of the CD0240 mutant, the flagellin of all mutants
was found react with the anti-β-O-GlcNAc antibody, however the parental strain 630Δerm and the CD0244 complement did not.
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of the plates; interestingly however this phenotype among
the modification mutants was the least pronounced in the
CD0240 mutant which had the strongest auto-aggregation
phenotype. In contrast the CD0243 mutant, for which we
previously observed no phenotypes, adhered to the abiotic
surfaces as well as the CD0241, CD0242 and CD0244
mutants.
The role of PTM in the epidemic ribotype 017 strains
The configuration of the 630 type A modification locus was
also identified in ribotype 017 strains, a distinct C. difficile
lineage, members of which have caused a number of
epidemics across Europe and Asia, but are toxin A nega-
tive (Drudy et al., 2007). To determine whether the prop-
erties associated with the PTM mutants in 630Δerm could
be extrapolated to the orthologues in the ribotype 017
strains, mutants were made in the strain M68Δerm, a
erythromycin-sensitive derivative of the ribotype 017
strain M68 isolated from an outbreak in Dublin (Drudy
et al., 2007; Faulds-Pain and Wren, 2013). An in-frame
deletion of the chromosomal ermB gene of M68, which we
had previously constructed, makes this strain sensitive to
macrolide, lincosamide, streptagramin (MLS) antibiotics
which are typically required for mutagenesis by Clostron
insertion (Faulds-Pain and Wren, 2013). The two genes
M68-0242 and M68-0243 (orthologues of CD0242 and
CD0243 respectively) were selected for mutagenesis as
the former had a strong phenotype in 630Δerm and the
latter a subtle phenotype. Motility of these mutants was
assayed and compared to 630Δerm and M68Δerm and
a fliC deletion mutant of M68, described previously
(Faulds-Pain and Wren, 2013). As in the 630Δerm back-
ground, the M68-0242 mutant caused a complete loss of
motility which was restored on complementation, while
the M68-0243 mutant was slightly less motile than the
parental strain (Fig. 7A and B).
Flagellin modification is essential for efficient
colonization and recurrence in the murine model
of infection
In a murine model, C. difficile can cause a self-limiting,
chronic intestinal infection by which colonization and
relapse can be studied (Chen et al., 2008; Lawley et al.,
2009). We used this model to assess the role of the
Δ
Δ
Δ
Δ
Δ
Δ
Δ
Δ
Fig. 5. Sedimentation of the modification mutants.
A. Mutations in the modification genes led cells to sediment in
liquid culture with the exception of CD0243, this phenotype was
restored by complementation in trans.
B and C. This was quantified during growth by measuring the OD600
of the top 1 ml of culture (top – continuous lines) and a well mixed
culture (mix – broken lines), demonstrating sedimentation in the
CD0240, CD0241, CD0242 and CD0244 mutants, confirming the
observations in A.
D. The sedimentation in double mutants of CD0241 and fliC,
CD0242 and fliC and CD0244 and fliC were also quantified. These
double mutants had a growth profile similar to the fliC clostron
mutant (B).
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flagellin modifications in the establishment and recur-
rence of C. difficile infection. In order to clear the natural
intestinal microflora and allow C. difficile to establish an
infection, clindamycin was administered to 8 week-old
C57BL/6 mice 5 days prior to challenge with C. difficile
spores derived from either 630Δerm or the isogenic fliC,
CD0241 or CD0243 mutants. Shedding of C. difficile in
the faeces was used as an indirect measure of host colo-
nization and was determined by plating emulsified faecal
pellets and enumerating the colony forming units (cfu) per
gram of faeces. In this model, colonization is transient and
detection of bacteria in the faeces is difficult 14 days post
infection. However, as low numbers persist, a second
dose of clindamycin administered approximately 28 days
post infection stimulates outgrowth and shedding, indicat-
ing relapse of infection, can be monitored.
Mice challenged with the parental strain 630Δerm shed
the bacteria at high levels from day 1 until day 4 post
challenge (approximately 5 × 106 cfu g−1 faeces), by day 7
the C. difficile load in the faeces had begun to fall (c.
1 × 104 cfu g−1 faeces) and by day 14 the load of C. difficile
in the faeces was below the limit of detection (Fig. 8A).
Recurrence of C. difficile shedding occurred 3 days after
the administration of a second dose of clindamycin
(experiment day 31). Shedding peaked after 4 days (day
32) (approximately 4.6 × 107 cfu g−1 faeces) and remained
high at 7 days (day 35), after 14 days (day 42) levels had
dropped almost to the level of detection of the experiment.
In these experiments mice challenged with the fliC
mutant both the initial infection and the relapse of infection
had a similar profile to the parental strain (Fig. 8A). The
most significant difference between these two strains was
that following the second dose of clindamycin C. difficile
shedding in the faeces recurred after 1 day in the mutant
(approximately 3 × 103 cfu g−1 faeces) compared to 3 days
in the parental strain. After 4 days (experiment day 32)
shedding of the fliC mutant peaked (approximately
Fig. 6. Agglutination of cells to one another and abiotic surfaces.
A and B. The autoagglutination of the modification mutants was
measured in the absence of media by growing them on solid media
and transferring them to PBS. The total autoagglutination was
calculated as the OD600 of the top 1 ml of cell solution compared to
the total OD600 following 16 h incubation. Autoagglutination was
found to be the highest in CD0240, CD0241, CD0242 and CD0244
mutants and could be restored on complementation, the fliC and
CD0243 mutant were similar to the parental strain.
C. The agglutination phenotype of the mutants was also
investigated in their interaction with abiotic surfaces, strains were
grown in 24-well plates for 5 days and the relative amount of cells
bound was measured with crystal violet stain. All of the modification
mutants showed a marked increase in binding to the surface of the
wells compared to 630Δerm and the fliC mutant.
Fig. 7. Motility in M68 putative modification mutants. Motility
assays of both the 630Δerm and M68Δerm parental strains
compared to the M68ΔfliC in-frame deletion mutant and the
mutations in the predicted modification genes M68_CD0242 and
M68_CD0243 were carried out in CDMM containing 0.3%
Difco-bacto agar. M68Δerm was motile and the M68_fliC mutant
non-motile, as described previously. A mutant of the M68_0242
gene was non-motile, this was restored upon complementation.
The M68_0243 mutant was motile, with a slightly reduced motility
compared to the parent.
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2.6 × 107 cfu g−1 faeces) and remained high at 7 days (day
35), as was observed in the parental strain.At 14 days (day
42) C. difficile was still detectable in the faeces but in low
numbers (approximately 1.2 × 103 cfu g−1 faeces). The
shedding profile of mice challenged with the CD0243
mutant was not significantly different to strain the fliC
mutant at any point post challenge or post second clinda-
mycin treatment (Fig. 8B). The delay in re-colonization
following the second dose of clindamycin observed in the
parental strain did not occur in any of the mutants tested.
As the Clostron mutants are marked with an ermB gene,
which confers resistance to clindamycin [minimum inhibi-
tory concentration (MIC) fliC = 16 μg ml−1, CD0241 =
8 μg ml−1 and CD0243 = 4 μg ml−1], while the parental
strain, 630Δerm is sensitive to this class of antibiotics
(MIC = 0.25 μg ml−1), it is likely that the clindamycin in the
mice inhibits the recurrence of 630Δerm but not the
mutants until the residual antibiotic is cleared.
Mice infected with spores of the CD0241 mutant
reached a similar level of shedding as the parental strain
Fig. 8. Flagellin modification is essential in
the colonization and recurrence of C. difficile
infection in C57BL/6 mice. Mice were
challenged with C. difficile spores (S) 5 days
following administration of clindamycin (C).
Levels of C. difficile were measured by plating
faecal samples and determining the C. difficile
cfu g−1.
A. Mice were challenged with the parental
strain 630Δerm (inverted grey triangles) and
the non-motile fliC Clostron mutant (black
circles). Initial colonization is similar in these
strains but relapse is delayed in 630Δerm by
2 days following the second dose of
clindamycin.
B. The initial colonization and relapse of the
fliC mutant (black circles) were compared to
the CD0241 and CD0243 modification
mutants (green triangles and light grey
squares respectively). While CD0243 has a
similar initial colonization and recurrence rate
to the fliC mutant, the CD0241 mutant is
defective in both initial colonization and
recurrence. Asterisks indicate a significant
difference compared to the fliC mutant.
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by day 2 post challenge; however, while the parental
strain and the fliC and CD0243 mutants continued to shed
at high levels until day 4, shedding of the CD0241 mutant
fell on day 3 and remained significantly lower than the fliC
mutant at day 4 (P = 0.04; Fig. 8B). This trend continued
at day 7 and at both days 9 and 11 the number of C.
difficile cfu in the faeces was almost at the limit of detec-
tion. Following the second dose of clindamycin, recur-
rence of infection by the CD0241 mutant did occur,
however the shedding of this mutant in the faeces was
significantly less than the fliC mutant at all time points
tested up to 10 days later (day 38) (P = 0.0011).
Weight change was monitored in the mice as another
marker of infection. The animals were weighed before
challenge and at 2 days post challenge with all four
strains. Those infected with 630Δerm, the fliC mutant and
the CD0243 mutant all lost weight in this time (between
2.3% and 6.3% of total body weight) compared to those
challenged with the CD0241 mutant (gained 5% body
weight). The difference in the change of weight in animals
challenged with this strain was significantly different than
630Δerm (P = 0.002), the fliC mutant (P = 0.008) and the
CD0243 (P = 0.01) mutant. It was also observed that the
mice challenged with either 630Δerm, the fliC mutant and
the CD0243 mutant produced sticky faeces in their cages,
a sign of significant infection, this was not observed in
those animals challenged with the CD0241 mutant.
In this experiment colonization of C57BL/6 mice and
disease recurrence does not appear to be reliant on bac-
terial motility or the presence of the flagellin in C. difficile
strain 630Δerm; however, disruption of the flagellin modi-
fication leads to attenuation in both colonization and
relapse.
Discussion
Treatment of C. difficile disease is extremely difficult and
relapse rates are high. Much work has been dedicated to
the study of C. difficile toxins as they are important in
disease and to sporulation and the spread of infection.
However, little is known about the organisms’ ability to
interact with and colonize the intestinal epithelia of the
host, a trait which may be vital in disease recurrence. In
this study, we defined the structure of the type A flagellin
post-translational modification by NMR and found that the
resultant change altered the extent of colonization and
outgrowth in the murine relapse model of infection.
Of the known flagellin modification structures only some
P. aeruginosa strains produce a structure composed of a
sugar plus a phosphate and a methylated amino acid,
similar to the C. difficile type A flagellin modification (Verma
et al., 2006). Interestingly, as with C. difficile, the P. aerugi-
nosa flagellins are also subject to strain-specific variation
of the PTMs, some being modified as the C. difficile type A
strain such as strain PA01 and others, such as the strain
PAK being modified with a larger glycan composed of a
number of monosaccharide moieties (Verma et al., 2006).
The precise role of this modification in P. aeruginosa has
not been determined; however, flagella are known to be
essential in the establishment of acute infections by P.
aeruginosa (Cobb et al., 2004). The C. difficile type A
flagellin modification was previously studied by LC-MS/MS
and the initial structure was assigned as a HexNAc sugar
with a methylated aspartic acid attached via a phosphate
bond (Twine et al., 2009). On further analysis however it
was realized that this amino acid was mis-identified as an
aspartic acid, the mass of the moiety attached to the
phosphate group being 115 Da is too small for an aspartic
acid plus a methyl group. In this study, to definitively
determine the structure of this modification a large-scale
extraction of C. difficile 630 flagellin was completed. The
flagellin protein was extensively digested with proteinase K
and following purification the glycan structure was solved
by NMR. The structural configuration of the HexNAc linking
sugar was confirmed to be β-O linked GlcNAc and the
remaining modification was linked via phosphate bond and
determined to be an N-methylthreonine residue in the
L-configuration.
Oligosaccharide flagellin modifications are commonly
formed of a series of sugars, predominantly pseudaminic
acid or its derivative legionaminic acid (Asakura et al.,
2010; Parker et al., 2012; Sun et al., 2013). Specialist
enzymes are required for the biosynthesis of these sugars
as they are not synthesized by the cell for any other
purpose (Parker et al., 2012; Sun et al., 2013). This is not
the case for the C. difficile type A flagellin modification, as
GlcNAc sugars are common precursors for many biosyn-
thetic pathways, therefore no specialized biosynthesis
genes are required. This is reflected in its modification
genes (Fig. 1), which are predicted to be involved in the
transfer of the modifications rather than the synthesis of
precursors.
By generating mutations of the C. difficile type A modifi-
cation genes and studying the resulting structures on the
flagella filaments by LC-MS/MS, we were able to define
more specifically the role each gene plays in the resulting
modification. Flagellins of the CD0241 and CD0242
mutants are modified with the GlcNAc sugar only and both
lack the phosphate group and the N-methylthreonine
residue (Fig. 2). This indicates that the addition of the
phosphate and the threonine to the GlcNAc is not sequen-
tial, but rather that they are added to the structure together.
These genes encode proteins which have similarity with
phosphoserine phosphatases and phosphocholine cytidy-
lyltransferases respectively. Phosphoserine phosphatases
catalyse the reversible reaction of serine and phosphate to
phosphoserine and H2O, and it seems likely that CD0241
could encode a kinase which catalyses the addition of
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phosphate to threonine (Fig. 9). This is supported by a
DXDX(T/V) motif encoded at the N-terminus of CD0241,
this domain functions as an intermediate phosphoryl
acceptor, indicative of a phosphatase (Osman et al.,
2010). Phosphocholine cytidylyltransferases catalyse the
reversible reactions of CTP plus choline phosphate to
CDP-choline and diphosphate. As there is no evidence of
phosphocholine in the flagellin modification, we hypoth-
esize that the enzyme encoded by CD0242 catalyses the
addition of the phosphothreonine to the GlcNAc residue
(Fig. 9).
LC-MS/MS of the putative methyltransferase knockout
(CD0243) identified a mixed population of glycan struc-
tures on flagellar peptides; either the GlcNAc residue alone
or the extended structure where the threonine was no
longer methylated. The former population indicates that
the function of this enzyme is to transfer a methyl group to
the threonine. This is represented as the final step in the
formation of the glycan in Fig. 9, however from our data we
cannot discern at what stage methylation occurs, whether
it is when the threonine is in complex with the glycan, when
it phosphorylated or when it is free threonine. The presence
of some residues which are modified with GlcNAc alone is
less easy to interpret; but it may indicate that when the
methyl group is absent the modification is less stable. It is
also unclear from our data what the function of the fourth
gene in the locus, CD0244, might be. The LC-MS/MS
analysis identifies a mixed population of both the wild-type
structure and the GlcNAc alone; however the phenotypic
characteristics of this mutant are the same as the CD0241
and CD0242 mutants. This predicted protein has some
similarity with glycerophosphotransferase enzymes; con-
sequently, we would predict that it is involved in the transfer
of the phosphate group to either the threonine or the
GlcNAc. This mixed population may indicate that this
enzyme is partially redundant. Interestingly, the similar
flagellin PTM cluster in P. aeruginosa PA01 strains con-
tains only orthologues of CD0241, CD0242 and CD0243,
with CD0244 absent, supporting this redundancy hypoth-
esis. This protein may however have a function not identi-
fied in this current study.
Previously, the CD0240 mutant, predicted to encode
the initial glycosyltransferase enzyme, was characterized
and found to be non-motile (Twine et al., 2009). Unusually
for strains with a mutation that prevents flagellin modifi-
cation, this knock-out was still able to both secrete flagel-
lin and form a filament. In this study we found that the
CD0241, CD0242 and CD0244 mutants likewise produce
flagella and are non-motile, but the mutant of CD0243
retained motility similar to the parental strain. Loss of
motility in flagellin PTM mutants in most organisms can be
explained by the absence of a flagella filament, this is not
the case for the C. difficile PTM mutants suggesting that
other properties of these unmodified or partially modified
filaments are interfering with motility. We noted another
property of these mutants was their tendency to aggre-
gate to each other and to surfaces and consequently to
sediment when grown in broth. This phenotype was inde-
pendent of motility and was dependent on the presence of
an unmodified or incompletely modified flagella filament.
One possible explanation is that an alteration in the flagel-
lin modifications affects the polarity of the cell surface,
causing the aggregation of the cells which prevents them
from swimming efficiently. An alternative hypothesis is that
the alteration in the charge on the flagellins is causing
deleterious changes in the regularity of filament pitch
height and length and consequently affecting the organ-
isms’ ability to swim efficiently.
The type A modification gene locus identified in 630 has
also been identified in the RT017 epidemic lineage of C.
difficile. We found that the phenotypes associated with the
type A modification mutants in 630Δerm were also asso-
ciated with mutants of their orthologues in the RT017
strain M68Δerm.
Fig. 9. Schematic diagram illustrates the
structure of the type A modification and the
predicted contribution of the enzymes to the
synthesis of the glycan. The FliC protein is
modified at seven serine and threonine
residues (grey oval represents a FliC
monomer with the curved line representing
either a serine or threonine amino acid within
the FliC protein). To these residues a GlcNAc
(black hexagon) is transferred by the GT
encoded by CD0240. A phosphate group
(white circle) is attached to a threonine (light
grey diamond) by the enzyme encoded by
CD0241 and this phosphorylated threonine is
attached to the FliC-GlcNac by the enzyme
encoded by CD0242. The methyltransferase
encoded by CD0243 adds a methyl group to
the threonine.
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Little is known about the advantages flagellin PTMs
provide a bacterium, although they have been implicated in
host colonization and virulence in a number of organisms
(Balonova et al., 2012; Iwashkiw et al., 2012; Lithgow
et al., 2014). Flagellin is a hugely abundant protein, promi-
nently displayed on the surface of the cell and PTMs are
localized to its externally exposed domains, indicating that
their function may lie in the interaction with the environ-
ment. C57BL/6 mice have been shown to be a useful
model for the study of C. difficile colonization and recur-
rence as they do not succumb to the overwhelming effects
of the toxins during infection (Chen et al., 2008; Lawley
et al., 2009). To investigate the role of flagellin, motility and
PTMs in the infection and relapse, these mice were chal-
lenged with the parent strain, 630Δerm, and the fliC,
CD0241 and CD0243 mutants. We found that the non-
motile fliC mutant and the motile CD0243 mutant had the
same profile of faecal C. difficile loads as 630Δerm during
both the initial infection and relapse, although the relapse
of clindamycin sensitive 630Δerm was delayed by 2 days
compared to the mutants. The Clostron mutagenesis
method used to generate our mutants requires an MLS
antibiotic sensitive parent strain, in this case 630Δerm, and
results in mutants marked with an ermB gene which
confers MLS antibiotic resistance. As clindamycin is a MLS
antibiotic and in this experiment it is used to trigger relapse,
it is likely that the delay in 630Δerm recurrence is due to its
sensitivity to clindamycin and the ability of the mutants to
immediately re-grow is due to their resistance. During the
initial infection the non-motile CD0241 mutant reached the
same peak of bacterial load in the faeces as the other three
strains however, this decreased much sooner and relapse
of infection was slower, peaked later and reached a lower
bacterial load in the faeces. These mice also avoided other
symptoms of severe infection such as weight loss and
sticky faeces.
We observed that neither flagella nor motility appear to
be required for the efficient colonization of C. difficile in
the mouse intestine, as had been described previously
(Baban et al., 2013). The complete modification of the
flagellin however does appear to be important in coloni-
zation and relapse. It is not known whether the CD0241
mutant aggregates in vivo as it does in vitro but it is
possible that this phenotype is affecting the fitness of the
bacteria or the hosts’ ability to clear it from the intestine.
Potentially the alteration in the modification structure
could affect the interaction of this highly abundant protein
with the hosts’ immune system.
Experimental procedures
Bacterial strains and growth conditions
Escherichia coli Top10 (Invitrogen) and E. coli CA434 were
grown at 37°C in Luria–Bertani (LB) growth media supple-
mented with chloramphenicol (12.5 μg ml−1) and CA434 with
Kanamycin (50 μg ml−1) where appropriate. C. difficile was
cultured at 37°C in an anaerobic work station (Don Whitley,
Yorkshire, UK) and grown routinely in BHIS medium (Brain
heart infusion medium supplemented with 5 mg ml−1 yeast
extract and 0.1% w/v L-cysteine). C. difficile was activated
from glycerol stocks on Braziers agar [CCEY (Bioconnec-
tions), 4% w/v egg yolk and 1% w/v defibrinated horse blood].
C. difficile was supplemented with D-cycloserine (250 μg ml−1),
cefoxitin (8 μg ml−1), thiamphenicol (15 μg ml−1) and erythro-
mycin (10 μg ml−1) where appropriate. Plasmids were trans-
ferred to C. difficile by conjugation from E. coli CA434 as
described previously (Heap et al., 2007; Cartman and Minton,
2010).
C. difficile minimal media (CDMM) (Cartman and Minton,
2010) containing 0.3% bacto-agar (DIFCO) was used to
assay motility of C. difficile strains, plates containing 35 ml
media were inoculated with a single colony using a sterile
toothpick and incubated for 3 days. Images were captured
using a Canon 600D SLR camera. Minimum inhibitory con-
centration (MIC) assays were performed as described previ-
ously (Andrews, 2001).
General molecular biology techniques
Plasmids were extracted using a plasmid mini kit (Qiagen)
and the genomic DNA with the DNeasy Blood and tissue kit
(Qiagen) following treatment with lysozyme (10 mg ml−1 in
phosphate-buffered saline at 37°C for 30 min), then SDS
(10% w/v) at 65°C for 30 min (Cartman and Minton, 2010) or
Chelex extraction [cell pellets vortexed in 5% chelex (Sigma)
boiled for 10 min, pelleted and the supernatants removed and
used] or by phenol-chloroform purification as described pre-
viously (Cartman and Minton, 2010). DNA was amplified for
cloning using Phusion high fidelity polymerase (NEB), and for
screening using Go-taq polymerase (Promega), both in
accordance with the manufacturers’ instructions. DNA was
extracted from PCR reactions and agarose gels using the
QIAquick PCR and gel extraction kits (Qiagen) respectively.
Allele exchange and complementation plasmids were con-
structed by restriction/ligation cloning using restriction endo-
nucleases, Antarctic phosphatase and T4 ligase (NEB).
Clostron plasmids were designed at http://www.clostron.com
and synthesized and cloned into pMTL007C-E2 by DNA2.0
(Heap et al., 2010).
Southern blot analysis was done using an intron specific
probe. One microgram of genomic DNA was digested over-
night with HindIII restriction enzyme (Promega). AlkPhosDi-
rectTM Labelling and detection kit (GE Healthcare) and
detection reagents, in accordance with the manufacturer’s
guidelines and visualized using CDP star (GE Healthcare).
Mutagenesis
C. difficile was mutated using the Clostron mutagenesis
system as described previously (Heap et al., 2007; 2010).
Briefly, gene-specific re-targeted Clostron plasmids (Table 2)
were transformed in to C. difficile by conjugation and transcon-
jugants selected for with thiamphenicol, mutants were then
positively selected with erythromycin and confirmed by PCR
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and Southern blot. Double mutants were made in C. difficile by
allele exchange using the method described previously
(Faulds-Pain and Wren, 2013). Briefly, the plasmid pAFP91
(Faulds-Pain and Wren, 2013) was transformed in to the C.
difficile 630Δerm Clostron mutants of CD0241, CD0242 and
CD0244 by conjugation and transconjugants selected for with
thiamphenicol, a series of replica plating on thiamphenicol
allowed single crossover integrants to be isolated, double
crossovers were then isolated by replica plating without selec-
tion and identified by their inability to grow on thiamphenicol.
Mutant construction was verified by PCR.
Construction of complementation vectors
The fliC complementation vector contained the genes own
promoter and terminator, the primers amplified from the end
of the TAA stop sequence of the gene immediately upstream
of the fliC and 196 bp downstream of the fliC stop site. The
PCR product was cloned into the C. difficile complementation
vector pMTL84151 (Heap et al., 2009; Table S1 for primers
and restriction sites). The CD0241 and CD0242 ORFs only
were amplified and cloned into the complementation vector
pMTL84153 (as the pMTL84151 vector but with an fdx
promoter/RBS and terminator) at the NdeI site, immediately
after the RBS in the vector and utilizes the ATG in its restric-
tion sequence. The CD0244 ORF already contains an NdeI
restriction site within its sequence therefore to utilize this
restriction site as with the other two ORFs, the internal NdeI
site was first removed by making a non-coding change in the
sequence by SOE-PCR. All constructs were confirmed by
restriction analysis and Sanger sequencing (SourceBiosci-
ence). In these three vectors expression of the complement
genes are driven by the non-native constitutive promoter from
the fdx gene of Clostridium pasteurianum.
Sedimentation growth curves
Sixty millilitres of BHIS broth was inoculated with a 1:100
dilution of an overnight culture, the inoculated broth was split
into 5 ml aliquots which were each allowed to grow statically.
At specific time points the top 1 ml of a 5 ml culture was
carefully removed from one replicate, while the second rep-
licate was mixed by vortexing and 1 ml of this mixed culture
was removed, the OD600 of both were measured. These cul-
tures were then disposed of and the subsequent OD600
reading taken from another pair of 5 ml cultures. Assays were
repeated in triplicate. Statistical analysis was done in Graph-
Pad Prism by two-way ANOVA and groups compared using a
Tukey’s multiple-comparisons test.
Autoagglutination assay
Strains of C. difficile grown overnight on BHIS agar were
resuspended in PBS and normalized to an OD600 of 10 in a
volume of 5 ml. Following incubation for 16 h at 37°C in the
anaerobic cabinet the top 1 ml of cells was removed and the
OD600 measured and the OD600 of the whole solution meas-
ured. Autoagglutination was calculated as the difference
between the OD600 of the whole solution and the OD600 of the
top 1 ml as a percentage of the whole solution OD. Assays
were repeated in triplicate.
Adherence to an abiotic surface
Overnight cultures of C. difficile were used to inoculate 2 ml
of BHIS in high bind 24-well plates at a 1:100 dilution. The
cultures were grown for 6 days after which the supernatant
was carefully removed and the wells washed with PBS. 1%
crystal violet was added to the wells and incubated at room
temperature for 20 min, the wells were then washed twice
with PBS and the remaining crystal violet was detached from
the cells attached to the surface of the wells with methanol.
The OD595 was measured in a Spectrophotometer (Biotek,
UK). Assays were repeated in triplicate.
Transmission electron microscopy
Cultures of C. difficile were inoculated 1:100 from overnight
culture and allowed to grow statically for the 6 h. An equal
volume of fixative (2.5% paraformaldehide, 2.5% glutaralde-
hide, 0.1 M Na cacodylate at pH 7.4) was added to the
cultures. Fixed samples were diluted in MilliQ water at a 1:6
dilution and 10 μl spotted on to a 400 mesh copper grid with
a pioloform support film and incubated for 1 min. Excess
liquid was then removed by pipetting and 10 μl of 0.3%
phosphotungstic acid (PTA) added in order to stain the
sample and incubated for 1 min. The excess PTA was drawn
off with filter paper and the grid air-dried before examining on
a Jeol JEM-1200EX II Transmission Electron Microscope
fitted with a 2K side mounted AMT (Advanced Microscopy
Techniques) CCD digital camera supplied by Debens UK Ltd
(http://www.debens.co.uk), used to record the digital images.
Low-pH glycine extractions
Cells from 18 h overnight cultures of C. difficile strains were
harvested, washed with phosphate buffered saline and
resuspended in a 1:100 volume of low-pH glycine (0.2 M
glycine-HCl, pH 2.2) and incubated at room temperature for
20 min with gentle shaking. The cells were removed by cen-
trifugation at 4°C and the supernatant neutralized with the
addition of 2M Tris to a pH of 7 to 8.
Purification of flagellar glycan for NMR analysis
Flagellar glycoprotein sample was digested with a large
excess of proteinase K in 0.01 M TRIS-HCl buffer at pH 8 at
37°C for 48 h. The products of digestion or free oligosaccha-
rides were separated on Bio-Gel P6 column (2.5 × 60 cm)
and each fraction which eluted before the salt peak was dried
and analysed by 1H NMR. Fractions containing sugars were
separated by anion exchange chromatography on Hitrap Q
column (5 ml size, Amersham) and the glycans eluted with a
linear gradient of NaCl (0–1 M, 1 h). Desalting was performed
on Sephadex G15 prior to analysis by NMR.
NMR spectroscopy analysis
NMR experiments were carried out on a Varian INOVA
500 MHz (1H) spectrometer with 3 mm gradient probe at
25°C with acetone internal reference (2.225 ppm for 1H and
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31.45 ppm for 13C) using standard pulse sequences
DQCOSY, TOCSY (mixing time 120 ms), ROESY (mixing
time 500 ms), HSQC and HMBC (100 ms long range transfer
delay). AQ time was kept at 0.8–1 s for H-H correlations and
0.25 s for HSQC, 256 increments was acquired for t1. For
1H-31P HMQC H-P coupling was set to 10 Hz.
Absolute configuration of N-methylthreonine
Glycopeptides were dephosphorylated with 48% HF (10
μl ml−1, 30 min, 30°C), dried by air stream, (R)-2-octanol
(0.2 ml) and acetyl chloride (0.02 ml) were added at room
temperature, heated at 100°C for 2 h, dried by air stream,
acetylated (0.2 ml Ac2O–0.2 ml pyridine, 100°C, 30 min),
dried, and analysed by GC-MS as described above. A stand-
ard was prepared from N-methyl-L-Thr (Sigma) by the same
procedure without the dephosphorylation step with (R)- or
(RS)-2-octanol. Analysis was performed on Agilent 6890 GC
instrument with DB17 column at 160–280°C by 4°C min−1.
In-gel digestion of flagellin proteins for mass
spectrum analysis
Flagellin gel bands were excised and destained using 25%
ethanol: 10% acetic acid. The gel bands were subsequently
dehydrated with the addition of acetonitrile. Fully dehydrated
gel bands were air dried under a laminar flow hood and then
digested over night with 20–50 μl of 20 ng μl−1 sequencing
grade modified trypsin in 50 mM Ammonium bicarbonate.
Digests were incubated at 37°C overnight. Peptides were
extracted into fresh microfuge tubes and stored at −20°C.
Mass spectral identification and de novo sequencing of
in-gel digested flagellins
Protein digests were analysed using a QTOF Ultima coupled
to a nanoAcquity UPLC system. Briefly, 10 μl of each digested
was injected onto a 180 μm ID × 20 mm, 5 μm symmetry C18
trap column in trapping mode, diverting flow through to waste.
Peptides were eluted by reversed phase liquid chromatogra-
phy (RPLC) to a 100 μm ID × 10 cm, 1.7 μm BEH130 C18
column (Waters) in analytical mode, using a linear gradient
from 1% to 45% solvent B in 18 min, 45% to 85% solvent B for
2 min, 85% to 1% solvent B over 1 min, and hold for 8 min at
1% solvent B. Tandem mass spectrometry analyses were
performed in data-dependent acquisition (DDA) mode. Peak-
list files were generated and searched against the C. difficile
630 translated genome sequence, using MASCOT (Matrix
Science) to identify unmodified peptides. The mass tolerance
for precursor and fragment ions was 0.8 Da and an ion score
of 30 or above indicated identity. In-house software ‘Glycan
Hunter’ performed peak listing of MS/MS spectra of
unmatched spectra that featured key glycan related ions,
using information from previously published studies (Twine
et al., 2009). Glycopeptides were identified by manual inspec-
tion of the MS/MS data, and de novo sequencing of peptide
related ions.
Western blot
The flagellin was isolated by low-pH glycine extractions in all
cases. For the anti-FliC Western blots the low-pH glycine
extraction was carried out as described above. Samples were
normalized according to the OD600 of the cultures and a total
volume of 15 μl was run on a Nu-Page 12% Bis-Tris SDS-
PAGE gel in MOPS running buffer (both Life Technologies).
Proteins were transferred to an H + membrane in a semi-dry
blotter in transfer buffer (0.24% Tris, 1.14% glycine and 20%
Methanol). The membrane was blocked in PBS plus 2% milk
(PBS-M) and probed with an anti-FliC antibody (a generous
gift from the Armstrong lab) at a 1 in 10 000 dilution for 1 h at
room temperature. Following standard membrane washing
with PBS-T (PBS plus 0.1% Tween 20) a Li-cor Donkey
anti-chicken IR Dye 680RD secondary antibody (Li-cor) was
added at a 1: 5000 in PBS-M plus 0.1% Tween 20 and 0.01%
SDS and incubated in the dark for 1 h. The membrane was
washed as before and visualized using a Li-cor Odyssey.
For the anti-GlcNAc Western blots, low-pH glycine extrac-
tion was achieved by scraping overnight growth of C. difficile
from plates and incubating the cells with low-pH glycine
buffer. Samples were standardized according to the OD600 of
the resuspended cells and protein separated on 12% Tris
Glycine gels, and transferred to a PVDF membrane. The
membrane was blocked with 5% milk-PBS-T then probed
with 1 in 5000 dilution of anti-β-O-GlcNAc (Covance, Mon-
treal, Canada) in PBS-T for 45 min at room temperature. After
washing with PBS-T, reactivity was detected with anti-mouse
IgM HRP conjugate (Sigma Aldrich, Oakville, Canada) sec-
ondary antibody at 1 in 10 000 dilution in PBS-T for 45 min at
room temperature. Blots were imaged with ECL Prime
Western blotting detection kit (GE Healthcare, Baie D’Urfe,
Canada) according to manufacturer’s guidelines, followed by
exposure to X-ray film.
Ethics statement
All procedures were strictly conducted according to the
requirements of the Animals (Scientific Procedures) Act 1986
approved by the Home Office, UK (project licence 60/4218).
Animal experiments
A total of 55 8-week-old C57BL/6 mice were housed in
groups of 5/6 a week before dosing with 150 mg kg−1 clinda-
mycin by oral gavage. Five days later animals were chal-
lenged with ∼ 1 × 105 spores/mouse C. difficile by oral gavage
and mouse weight and body condition monitored throughout
the study. Cages were changed weekly and the cabinet
washed with perasafe after each group. To monitor C. difficile
shedding faecal pellets from individuals were collected, seri-
ally diluted and plated on CCEY agar supplemented with
cycloserine/cefoxitin, egg yolk emulsion and 15 μg ml−1 linco-
mycin (for mutants only). At 28 days post challenge, once C.
difficile shedding levels were below the limit of detection,
mice were given a second dose of clindamycin (150 mg kg−1)
and shedding monitored for infection relapse. Results are
expressed as mean ± SE of at least 10 animals from two
independent biological replicates. All statistical analyses
were performed using the GraphPad Instat 3.10 (GraphPad
Instat Software). A Mann–Whitney analysis of variance analy-
sis (ANOVA) was used to determine significant difference in
bacterial recoveries between all time points examined.
P-values ≤ 0.05 were considered significant.
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PCR was performed on colonies obtained from faecal
shedding to determine the validity of the shedding strain. For
the clostron mutants, gene-specific primers in combination
with the universal EBS primer was used in PCR reactions,
while for 630Δerm MLVA PCR analysis was used to confirm
the identity of the shedding of this strain (Table S1). PCRs
were done 1 day post challenge and weekly thereafter.
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